Re: ANYTHING ON THE SHOWCASE?

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: ANYTHING ON THE SHOWCASE?

posted on Jan 09, 2018 10:11AM

Noretreat,

I wish I could help shed some light but both Resverlogix and Zenith have gone silent as I elaborated in this message on the Resverlogix hub and copied below.

BearDownAZ

-----------------------

Hartland,

I was not there at Biotech Showcase. However, as I stated yesterday in a previous message, I emailed both Resverlogix and Zenith yesterday. I inquired about the presentations and whether they plan to news release about the conference or post the slide deck as they normally do. But as of now no response. In the past they've advertised with news release in advance or day of the conference, or at least listed the event on the company website, and typically posted slides at the time of the event. None of the above so far. Even their twitter feed has no info.

Last year was much different, as shown in this Biotech 2017 news release from Resverlogix and this Biotech 2017 news releasefrom Zenith.

In my opinion, it is perfectly justified (both as an individual investor and a hub leader) to question and criticize the communications of both companies.